Non-Invasive Retinal Vessel Analysis as a Predictor for Cardiovascular Disease

Raluca Eugenia Iorga,Damiana Costin,Răzvana Sorina Munteanu-Dănulescu,Elena Rezuș,Andreea Dana Moraru
DOI: https://doi.org/10.3390/jpm14050501
IF: 3.5083
2024-05-09
Journal of Personalized Medicine
Abstract:Cardiovascular disease (CVD) is the most frequent cause of death worldwide. The alterations in the microcirculation may predict the cardiovascular mortality. The retinal vasculature can be used as a model to study vascular alterations associated with cardiovascular disease. In order to quantify microvascular changes in a non-invasive way, fundus images can be taken and analysed. The central retinal arteriolar (CRAE), the venular (CRVE) diameter and the arteriolar-to-venular diameter ratio (AVR) can be used as biomarkers to predict the cardiovascular mortality. A narrower CRAE, wider CRVE and a lower AVR have been associated with increased cardiovascular events. Dynamic retinal vessel analysis (DRVA) allows the quantification of retinal changes using digital image sequences in response to visual stimulation with flicker light. This article is not just a review of the current literature, it also aims to discuss the methodological benefits and to identify research gaps. It highlights the potential use of microvascular biomarkers for screening and treatment monitoring of cardiovascular disease. Artificial intelligence (AI), such as Quantitative Analysis of Retinal vessel Topology and size (QUARTZ), and SIVA–deep learning system (SIVA-DLS), seems efficient in extracting information from fundus photographs and has the advantage of increasing diagnosis accuracy and improving patient care by complementing the role of physicians. Retinal vascular imaging using AI may help identify the cardiovascular risk, and is an important tool in primary cardiovascular disease prevention. Further research should explore the potential clinical application of retinal microvascular biomarkers, in order to assess systemic vascular health status, and to predict cardiovascular events.
medicine, general & internal,health care sciences & services
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is: predicting the risk of cardiovascular disease (CVD) through non - invasive retinal vessel analysis. Specifically, the study aims to explore whether retinal microvascular changes can be used as early biomarkers of cardiovascular disease and evaluate the potential applications of these changes in the prevention and management of cardiovascular disease. ### Research Background and Problem Description 1. **High Incidence and Mortality of Cardiovascular Disease**: - Cardiovascular disease is the most common cause of death worldwide. - Changes in the microcirculation may indicate an increased risk of cardiovascular mortality. - Early detection and prevention of cardiovascular disease are crucial. 2. **Retinal Vessels as a Research Model**: - Retinal vessels are a unique biological model that can be used to study microvascular abnormalities related to cardiovascular disease. - Retinal vessels are known as the "window to the heart", meaning that retinal parameters may serve as biomarkers for cardiovascular disease. 3. **Non - Invasive Retinal Vessel Analysis Methods**: - Static Retinal Vessel Analysis (SRVA): Central retinal artery equivalent diameter (CRAE), central retinal vein equivalent diameter (CRVE) and arteriovenous diameter ratio (AVR) are measured through fundus images to predict cardiovascular mortality. - Dynamic Retinal Vessel Analysis (DRVA): Digital image sequences are used to quantify the changes in the retinal response to flickering light stimulation. 4. **Application of Artificial Intelligence**: - AI technologies such as QUARTZ and SIVA - DLS have shown high efficiency in extracting information from fundus photographs, which helps to improve diagnostic accuracy and patient care. ### Research Objectives - **Evaluating Retinal Microvascular Biomarkers**: Explore the relationships between parameters such as CRAE, CRVE and AVR and cardiovascular events. - **Identifying Research Gaps**: Discuss the advantages of current methodologies and identify the deficiencies in the research. - **Exploring Clinical Application Potential**: Evaluate the clinical application potential of retinal microvascular biomarkers in the assessment of systemic vascular health status and the prediction of cardiovascular events. Through these studies, the paper hopes to provide new tools and methods for the early screening and treatment monitoring of cardiovascular disease, so as to better prevent and manage cardiovascular disease.